Total Funding
37
Total FundingSeries C raised
Growth Score
pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
58330
Imago is a clinical stage biopharmaceutical company that develops drugs for the management of proliferative diseases of the bone marrow.
Xi Chen: Director, Analytical ChemistryPast Role: PixarBio, Director, Analytical Chemistry- Michael Arenberg: Chief Operating Officer and Chief Business Officer
About the Company
Imago BioSciences is a clinical development company dedicated to translating state-of-the art science into novel medicines for treating diseases that currently pose great challenges to patients, their families and their physicians. The company leverages the skills and extensive experience of its team and the financial commitment of its investors to
focus on a small family of orphan diseases. Imago BioSciences translates unique insights into high impact transformative therapies that alter the natural history of disease allowing patients to live longer, disease-free lives.
Imago BioSciences was founded in 2012 and is based in Redwood City, California.
